JP2005501855A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005501855A5 JP2005501855A5 JP2003521215A JP2003521215A JP2005501855A5 JP 2005501855 A5 JP2005501855 A5 JP 2005501855A5 JP 2003521215 A JP2003521215 A JP 2003521215A JP 2003521215 A JP2003521215 A JP 2003521215A JP 2005501855 A5 JP2005501855 A5 JP 2005501855A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- unsubstituted
- compound represented
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(*)(*)C(C(*)(*)C(C(*)=O)=C(*)NCc1nc(*)nc(NC(*)=C(C(C)(*)C(C(*)(*)*)=O)C(*)=O)n1)=O Chemical compound CC(*)(*)C(C(*)(*)C(C(*)=O)=C(*)NCc1nc(*)nc(NC(*)=C(C(C)(*)C(C(*)(*)*)=O)C(*)=O)n1)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01810796 | 2001-08-17 | ||
| CH16992001 | 2001-09-14 | ||
| PCT/EP2002/008888 WO2003016289A1 (en) | 2001-08-17 | 2002-08-08 | Triazine derivatives and their use as sunscreens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005501855A JP2005501855A (ja) | 2005-01-20 |
| JP2005501855A5 true JP2005501855A5 (enExample) | 2006-01-05 |
| JP4344241B2 JP4344241B2 (ja) | 2009-10-14 |
Family
ID=25739004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003521215A Expired - Fee Related JP4344241B2 (ja) | 2001-08-17 | 2002-08-08 | トリアジン誘導体、およびサンスクリーンとしてのその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7038046B2 (enExample) |
| EP (1) | EP1423371B1 (enExample) |
| JP (1) | JP4344241B2 (enExample) |
| AT (1) | ATE485281T1 (enExample) |
| DE (1) | DE60238066D1 (enExample) |
| DK (1) | DK1423371T3 (enExample) |
| WO (1) | WO2003016289A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6748471B1 (en) * | 2000-10-16 | 2004-06-08 | Electronics For Imaging, Inc. | Methods and apparatus for requesting and receiving a print job via a printer polling device associated with a printer |
| US7574545B2 (en) * | 2000-10-16 | 2009-08-11 | Electronics For Imaging, Inc. | Method and apparatus for controlling a document output device with a control request stored at a server |
| FR2867188A1 (fr) * | 2004-03-03 | 2005-09-09 | Oreal | Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri |
| US20070286827A1 (en) * | 2006-06-12 | 2007-12-13 | Esschem, Inc. | Optical brighter and uv stabilizer for acrylic enhancements |
| US20080026109A1 (en) * | 2006-06-29 | 2008-01-31 | Martek Biosciences Corporation | Sweetened Oil Compositions and Methods of Making |
| ZA200900839B (en) * | 2006-08-24 | 2010-05-26 | Unilever Plc | Photostable cosmetic compositions |
| US20080096782A1 (en) * | 2006-10-19 | 2008-04-24 | L'oreal | Aqueous systems containing phospholipid, surfactant and phosphate ester for water-insoluble materials |
| US20080097070A1 (en) * | 2006-10-19 | 2008-04-24 | L'oreal | Aqueous polyamine-containing systems for water-insoluble materials |
| EP2406389B1 (en) | 2009-03-13 | 2019-05-08 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| CA2944788C (en) | 2009-06-29 | 2023-08-22 | Agios Pharmaceuticals, Inc. | Compounds, and compositions thereof, which modulate pyruvate kinase m2, and methods of making same |
| CA2793835C (en) | 2009-10-21 | 2021-07-20 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| CA2792018A1 (en) | 2010-05-10 | 2011-11-17 | Segetis, Inc. | Fragrant formulations, methods of manufacture thereof and articles comprising the same |
| KR101856808B1 (ko) | 2010-12-28 | 2018-05-10 | 닛산 가가쿠 고교 가부시키 가이샤 | 폴리이미드막 형성용 도포액, 액정 배향제, 폴리이미드막, 액정 배향막 및 액정 표시 소자 |
| US9040030B2 (en) * | 2010-12-30 | 2015-05-26 | L'oreal | Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax |
| KR101873543B1 (ko) | 2011-05-03 | 2018-07-02 | 아지오스 파마슈티컬스 아이엔씨. | 치료에 사용하기 위한 피루베이트 키나아제 활성제 |
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| CN102827170A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| SG11201403878QA (en) | 2012-01-06 | 2014-08-28 | Agios Pharmaceuticals Inc | Therapeutically active compounds and their methods of use |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| HK1213798A1 (zh) | 2012-10-15 | 2016-07-15 | 安吉奥斯医药品有限公司 | 治療性化合物和組合物 |
| WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| WO2015003360A2 (en) * | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| CA2917671A1 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | 2,4-or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer |
| US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| NZ715738A (en) | 2013-07-11 | 2021-06-25 | Agios Pharmaceuticals Inc | N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer |
| US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| CA2942072C (en) | 2014-03-14 | 2022-07-26 | Agios Pharmaceuticals, Inc. | Pharmaceutical compositions and use of (s)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-( 4-cyanopyridin-2-yl)-n-( 5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide |
| DK3307271T3 (da) | 2015-06-11 | 2023-10-09 | Agios Pharmaceuticals Inc | Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer |
| MA71411A (fr) | 2015-10-15 | 2025-04-30 | Les Laboratoires Servier | Polythérapie pour le traitement de tumeurs malignes |
| DK3362066T3 (da) | 2015-10-15 | 2021-11-22 | Les Laboratoires Servier Sas | Kombinationsterapi til behandling af maligniteter |
| CN107827764A (zh) * | 2017-11-27 | 2018-03-23 | 上海应用技术大学 | 一种双β‑氨基酮或双β‑氨基酯类的制备方法 |
| US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4105923A1 (de) | 1991-02-26 | 1992-08-27 | Basf Ag | P-aminozimtsaeure-substituierte triazine |
| DE4223890A1 (de) * | 1992-02-19 | 1993-08-26 | Merck Patent Gmbh | Triazin-derivate |
| FR2744721B1 (fr) * | 1996-02-12 | 1999-06-18 | Oreal | Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations |
-
2002
- 2002-08-08 AT AT02772133T patent/ATE485281T1/de not_active IP Right Cessation
- 2002-08-08 WO PCT/EP2002/008888 patent/WO2003016289A1/en not_active Ceased
- 2002-08-08 JP JP2003521215A patent/JP4344241B2/ja not_active Expired - Fee Related
- 2002-08-08 DK DK02772133.1T patent/DK1423371T3/da active
- 2002-08-08 EP EP02772133A patent/EP1423371B1/en not_active Expired - Lifetime
- 2002-08-08 DE DE60238066T patent/DE60238066D1/de not_active Expired - Lifetime
- 2002-08-08 US US10/486,761 patent/US7038046B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005501855A5 (enExample) | ||
| JP2005538072A5 (enExample) | ||
| JP2006515613A5 (enExample) | ||
| RU2203894C2 (ru) | Новые производные пиримидина (варианты) | |
| JP2009519993A5 (enExample) | ||
| HUP0203841A2 (en) | 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them | |
| CY1108652T1 (el) | Παραγωγα μορφολινυλ-ουριας για χρηση στη θεραπεια φλεγμονωδων ασθενειων | |
| PE20130385A1 (es) | Derivados del acido naft-2-ilacetico para tratar el sida | |
| RU2007139453A (ru) | Гетеробициклические ингибиторы вируса гепатита с (hcv) | |
| JP2006523197A5 (enExample) | ||
| JP2005535586A5 (enExample) | ||
| AR037485A1 (es) | Uso de un compuesto derivado de pirazol-triazina en la fabricacion de un medicamento, medicamento que comprende un compuesto derivado de pirazol-triazina, producto industrial y composicion farmaceutica | |
| JP2012508252A5 (enExample) | ||
| KR960701878A (ko) | 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents) | |
| JP2005529869A5 (enExample) | ||
| ATE433969T1 (de) | Pyrimidine verbindungen | |
| AR034679A1 (es) | Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria | |
| PE20030455A1 (es) | Ciclohexilsulfonas como moduladores del procesamiento de proteina precursora amiloide por gamma secretasa | |
| RU2018115718A (ru) | Терапевтические соединения и способы их применения | |
| RU2010147826A (ru) | Ацилоксиалкилкарбаматные пролекарства, способы синтеза и применение | |
| RU2004126637A (ru) | Производные порфиринплатины, терапевтические активное соединение для получения средства для лечения опухолей, лекарственное средство и способ получения указанного средства | |
| JP2005539099A5 (enExample) | ||
| JP2003026675A5 (enExample) | ||
| JP2004529091A5 (enExample) | ||
| JP2005526073A5 (enExample) |